FIELD: medicine.
SUBSTANCE: for estimating clinical effectiveness, patients suffering chronic conditions of nose and accessory sinuses of nose are examined for a degree of nonspecific resistance of a nasal mucosa by calculating a thiol-disulphide balance K=SH/SS, and a number of SH and -SS groups in a nasal secretion. The values K=1.2-1.9 enables to estimate a degree of nonspecific resistance of the nasal mucosa as low, and clinical effectiveness is considered to be negative. If K=2.0-2.7, a degree of nonspecific resistance is estimated as low, clinical effectiveness is positive, however requiring to be prolonged. The value K=2.8-3.5 provides a high degree of nonspecific resistance and positive clinical effectiveness.
EFFECT: invention allows precise and quick estimation of clinical effectiveness.
5 tbl, 3 ex, 6 dwg
| Title | Year | Author | Number | 
|---|---|---|---|
| METHOD OF TREATMENT OF CHILDREN'S CHRONIC INFLAMMATORY NOSE DISEASES | 1996 | 
 | RU2127133C1 | 
| METHOD OF EVALUATING THE EFFICIENCY OF MEDICAMENTAL THERAPY OF ACUTE EXACERBATIONS OF CHRONIC PURULENT SINUSITIS | 2015 | 
 | RU2600645C2 | 
| PREDICTION METHOD OF POLYPOUS RHINOSINUSITIS RELAPSE RISK FOR PREVENTIVE THERAPY INDICATIONS | 2007 | 
 | RU2338205C1 | 
| METHOD OF TREATING CHRONIC RECURRING INFLAMMATORY DISEASES OF NASAL CAVITY AND PARANASAL SINISES BY METHOD OF ENDONASAL AUTOLYMPHOCYTO THERAPY | 2009 | 
 | RU2403071C1 | 
| METHOD FOR TREATING CHRONIC POLYPOUS RHINOSINUSITIS | 2000 | 
 | RU2163097C1 | 
| METHOD FOR EVALUATING THE STATE OF LOCAL IMMUNITY OF NASAL CAVITY MUCOSA IN RHINOLOGICAL PRACTICE | 2006 | 
 | RU2297633C1 | 
| METHOD OF POLYPOUS RHINOSINUSITIS TREATMENT | 2017 | 
 | RU2646806C1 | 
| METHOD FOR NON-INVASIVE TREATMENT OF PARANASAL RHINOSINUSITIS IN ADULTS AND CHILDREN | 2012 | 
 | RU2509576C2 | 
| METHOD FOR SELECTING TARGETED THERAPY IN CHRONIC T2-INFLAMMATORY DISEASES OF NASAL CAVITY AND PARANASAL SINUSES | 2023 | 
 | RU2824263C1 | 
| METHOD FOR PHENOTYPE DETERMINATION OF CHRONIC INFLAMMATORY DISEASES OF NOSE AND PARANASAL SINUSES IN CASE OF INDICATIONS FOR TARGETED THERAPY | 2023 | 
 | RU2826780C1 | 
Authors
Dates
2011-10-20—Published
2010-05-25—Filed